» Articles » PMID: 11861380

The Androgen Receptor CAG Repeat Polymorphism and Risk of Breast Cancer in the Nurses' Health Study

Overview
Journal Cancer Res
Specialty Oncology
Date 2002 Feb 28
PMID 11861380
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Shorter alleles of a polymorphic [CAG](n) repeat in exon 1 of the androgen receptor (AR) have been associated with increased risk of prostate cancer and decreased risk of breast cancer. We prospectively assessed the association between the [CAG](n) repeat polymorphism in the androgen receptor and breast cancer risk among Caucasian women in a case-control study nested within the Nurses' Health Study cohort (cases, n = 727; controls, n = 969). In addition, we assessed whether androgen receptor genotype influences endogenous steroid hormone levels in women and whether the associations between androgen receptor alleles and breast cancer risk differed according to established breast cancer risk factors. Women with one or more long AR [CAG](n) repeat alleles (>or=22 repeats) were not at increased risk of breast cancer [odds ratio (OR), 1.06; 95% confidence interval (CI), 0.83-1.35]. Significant associations were not observed between AR genotypes comprised of two short alleles ([CAG](n) <or=20 versus both alleles >or=22: OR, 0.92; 95% CI, 0.62-1.36) or two long alleles ([CAG](n) >or= 25 versus both alleles <or= 22: OR, 1.42; 95% CI, 0.81-2.50) and breast cancer risk. We also observed no strong overall association between average repeat length and breast cancer risk (OR, 1.04 per CAG repeat; 95% CI, 0.99-1.10) or between average repeat length and plasma hormone levels. We also examined the cross-classification of AR genotype and first-degree family history of breast cancer. Compared with women with both alleles <22 and no family history, we observed a significant positive association limited to women with both a first-degree family history of breast cancer and longer alleles (one or two [CAG](n) alleles >or=22; OR, 1.70; 95% CI, 1.20-2.40; P for interaction = 0.04). In summary, we observed no overall relation of AR genotype with breast cancer risk among mostly postmenopausal Caucasian women. However, these data suggest that longer AR [CAG](n) repeat alleles may increase breast cancer risk among women with a first-degree family history of breast cancer.

Citing Articles

The Other Side of the Coin: May Androgens Have a Role in Breast Cancer Risk?.

Chiodo C, Morelli C, Cavaliere F, Sisci D, Lanzino M Int J Mol Sci. 2022; 23(1).

PMID: 35008851 PMC: 8745651. DOI: 10.3390/ijms23010424.


Integration of VDR genome wide binding and GWAS genetic variation data reveals co-occurrence of VDR and NF-κB binding that is linked to immune phenotypes.

Singh P, van den Berg P, Long M, Vreugdenhil A, Grieshober L, Ochs-Balcom H BMC Genomics. 2017; 18(1):132.

PMID: 28166722 PMC: 5294817. DOI: 10.1186/s12864-017-3481-4.


CAG repeat polymorphisms in the androgen receptor and breast cancer risk in women: a meta-analysis of 17 studies.

Mao Q, Qiu M, Dong G, Xia W, Zhang S, Xu Y Onco Targets Ther. 2015; 8:2111-20.

PMID: 26316780 PMC: 4540135. DOI: 10.2147/OTT.S85130.


Trinucleotide repeat expansions in human breast cancer-susceptibility genes: relevant targets for aspirin chemoprevention?.

Altinoz M, Tunali N Clin Transl Oncol. 2015; 18(1):9-17.

PMID: 26199016 DOI: 10.1007/s12094-015-1356-1.


Androgen receptor CAG repeats, non-random X chromosome inactivation, and loss of heterozygosity at Xq25 in relation to breast cancer risk.

Chen H, Wu Y, Chen S, Tsai H, Chien Y BMC Cancer. 2014; 14:144.

PMID: 24581183 PMC: 3975944. DOI: 10.1186/1471-2407-14-144.